Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda.
Thompson RR, Kityamuwesi A, Kuan A, Oyuku D, Tucker A, Ferguson O, Kunihira Tinka L, Crowder R, Turyahabwe S, Cattamanchi A, Dowdy DW, Katamba A, Sohn H. Thompson RR, et al. Among authors: kunihira tinka l. Value Health. 2022 Jun;25(6):924-930. doi: 10.1016/j.jval.2021.12.002. Epub 2022 Jan 6. Value Health. 2022. PMID: 35667781 Free article. Clinical Trial.
Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda.
Berger CA, Kityamuwesi A, Crowder R, Lamunu M, Kunihira Tinka L, Ggita J, Sanyu Nakate A, Namale C, Oyuku D, Chen K, Turyahabwe S, Cattamanchi A, Katamba A. Berger CA, et al. Among authors: kunihira tinka l. J Clin Tuberc Other Mycobact Dis. 2020 Sep 12;21:100184. doi: 10.1016/j.jctube.2020.100184. eCollection 2020 Dec. J Clin Tuberc Other Mycobact Dis. 2020. PMID: 33204851 Free PMC article.
Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods.
Patel D, Berger CA, Kityamuwesi A, Ggita J, Kunihira Tinka L, Turimumahoro P, Feler J, Chehab L, Chen AZ, Gupta N, Turyahabwe S, Katamba A, Cattamanchi A, Sammann A. Patel D, et al. Among authors: kunihira tinka l. JMIR Form Res. 2020 Dec 8;4(12):e19270. doi: 10.2196/19270. JMIR Form Res. 2020. PMID: 33289494 Free PMC article.
Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda.
Sung J, Musinguzi A, Kadota JL, Baik Y, Nabunje J, Welishe F, Bishop O, Berger CA, Katahoire A, Nakitende A, Nakimuli J, Akello L, Kasidi JR, Kunihira Tinka L, Kamya MR, Sohn H, Kiwanuka N, Katamba A, Cattamanchi A, Dowdy DW, Semitala FC. Sung J, et al. Among authors: kunihira tinka l. Int J Tuberc Lung Dis. 2023 Jun 1;27(6):458-464. doi: 10.5588/ijtld.22.0679. Int J Tuberc Lung Dis. 2023. PMID: 37231600
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
Kiwanuka N, Kityamuwesi A, Crowder R, Guzman K, Berger CA, Lamunu M, Namale C, Kunihira Tinka L, Nakate AS, Ggita J, Turimumahoro P, Babirye D, Oyuku D, Patel D, Sammann A, Turyahabwe S, Dowdy DW, Katamba A, Cattamanchi A. Kiwanuka N, et al. Among authors: kunihira tinka l. PLOS Digit Health. 2023 Jun 30;2(6):e0000138. doi: 10.1371/journal.pdig.0000138. eCollection 2023 Jun. PLOS Digit Health. 2023. PMID: 37390077 Free PMC article.
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Semitala FC, Kadota JL, Musinguzi A, Welishe F, Nakitende A, Akello L, Kunihira Tinka L, Nakimuli J, Ritar Kasidi J, Bishop O, Nakasendwa S, Baik Y, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A. Semitala FC, et al. Among authors: kunihira tinka l. PLoS Med. 2024 Feb 20;21(2):e1004356. doi: 10.1371/journal.pmed.1004356. eCollection 2024 Feb. PLoS Med. 2024. PMID: 38377166 Free PMC article. Clinical Trial.